COCP vs EMR · rev $105.0K vs P/E 34, rev $4.86B
Cocrystal Pharma Inc (COCP) versus Emerson Electric Company (EMR) — a side-by-side from cached financials, not a winner call.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
Emerson Electric Company (EMR) is a specialty industrial machinery company listed on NYSE.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
Latest reported EMR revenue for 2025-09-30 was $4.86B. Net income was $2.25B. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
COCP currently screens at market cap $13.3M. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
Not investment advice. Open the COCP and EMR stock pages for the full models.
Not investment advice.